AstraZeneca’s chronic obstructive pulmonary disease (COPD) candidate has hit the mark in a pair of phase 3 trials, delivering broad efficacy with a mechanism that yielded mixed data for Roche and ...

Cracker Barrel reported a drop in quarterly revenue and profit as the company continues to recover from last summer’s rebranding controversy, though CEO Julie Masino says early signs of a turnaround ...

Forbes contributors publish independent expert analyses and insights. Emily writes about what’s in your glass and why it matters. Connecticut-based Proof & Wood walked away with one of the night’s top ...

The therapeutic variations among patients with chronic obstructive pulmonary disease (COPD) present ongoing treatment challenges. However, the two currently approved biologics, dupilumab and ...

Prefer Newsweek on Google to see more of our trusted coverage when you search. Cracker Barrel is ushering in a spree of changes to its restaurants this year, and that several new menu items will be ...

Step into the Golden Era and discover how Incredible Hulk legend Lou Ferrigno built a massive, granite-like physique. This video breaks down his brutal high-volume training style, heavy iron ...

Cracker Barrel warned during the company's earnings call on Tuesday that its turnaround is moving at a slower pace than hoped after the company was mired in controversy over the summer after an ...

Cracker Barrel's CEO said the chain is working to rebuild customer trust after its logo controversy earlier this year marked a quarter of declining sales. During its quarterly financial results call ...

Cracker Barrel is offering Heat n' Serve holiday meals that are ready in three hours or less. Meal options include Prime Rib and Holiday Ham dinners that serve between four and 10 people. Heat n' ...

Cracker Barrel CEO Julie Masino described feeling as though she was “fired by America” in an interview last week following the backlash over the restaurant’s controversial remodeling design. Masino ...

Please provide your email address to receive an email when new articles are posted on . Patients receiving roflumilast vs. azithromycin had a reduced risk for COPD exacerbations at 1 year but an ...

Achieving a deep, barrel chest is a physique goal many men chase. To get there, some focus on adding pounds to their bench press, while others grind through endless cable fly variations. But if ...